WASHINGTON – The U.S. House and Senate are poised to suspend a sales tax on medical devices for two years after intense lobbying on behalf of the medical technology industry that employs tens of thousands of people in Minnesota.
The government began collecting the 2.3 percent tax on device sales in January 2013 to help pay for national health care reform. But a new tax deal announced Wednesday suspends those collections until Dec. 31, 2017.
"This is pretty miraculous," said Shaye Mandle, CEO of LifeScience Alley, Minnesota's med tech trade group. "It's unusual to see a tax that's being collected taken away. Certainly we want this to become permanent."
Mandle says that is especially important in Minnesota, which LifeScience Alley touts as the state with "the most geographically concentrated per capita medical device footprint in the world."
In the United States, Minnesota ranks second to California in the absolute number of residents employed in medical technology with 40,000 workers spread across hundreds of companies including major players like Medtronic, St. Jude Medical and Boston Scientific.
Through trade groups and with individual expenditures, many of these companies have battled the device tax since its inclusion in the Affordable Care Act (ACA) in 2010. The lobbying tab has run to millions of dollars.
'Important step'
The device tax suspension is part of a huge tax package that extends tax breaks for businesses and low-income people and makes dozens of those breaks permanent.
The tax break package is expected to pass the House on Thursday and be considered later by the Senate. It may or may not be rolled into a budget bill that must pass to keep the government running.